Skip to content
Home/Companies/Healthcare/IntelliBio
IN

IntelliBio

Healthcare·China·Exited 2023·Held 4yr

IntelliBio is a healthcare company, headquartered in China.

Entry
2019
Hold
4yr
Exit
2023
Est. EV
–

Who owns IntelliBio?

IntelliBio was owned by Cathay Capital through Cathay Capital Small Cap III (2016 vintage) from 2019 to 2023, exited via Trade Sale.

Hand-verified · updated 2026-04-21

Cathay Capital
Investor
Cathay Capital
Cathay Capital Small Cap III · 2016 · Growth

Key facts

HQChina
SectorHealthcare
Exit Type
Trade Sale
Buyer
–
MOIC
–
Exit Year
2023

More from Cathay Capital Small Cap III

Other portfolio companies in the same fund.

Aukey
Active
ConsumerChina· 2020
Biose Industrie
Exited 2024
HealthcareFrance· 2020
to
Brosmed
Active
HealthcareChina· 2020
Deerma
Active
ConsumerChina· 2020
EasyVista
Active
SoftwareFrance· 2020
Fapon
Active
HealthcareChina· 2020

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
A Place for Mom
Active
Silver LakeUS
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abbisko Healthcare
Active
The Carlyle GroupChina
Abode Healthcare
Active
Summit PartnersUS
AccentCare
Active
Advent InternationalUS
Data refreshed weekly · Sourced from public filings